Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery
Market Report
2024
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Report 2023.
According to Cognitive Market Research, the global Next Generation Diabetes Therapy and Drug Delivery market size was estimated at USD 10215.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 204.31 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031..
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Sales Revenue 2024 | $ 204.31 Million |
Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Compound Annual Growth Rate (CAGR) for 2023 to 2030 | 14.9% |
Market Split by Product |
|
Market Split by Demographic |
|
Market Split by Indication |
|
Market Split by End User |
|
List of Competitors | Competitors not disclose (Request Sample) |
Country Analysis | Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA | Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Read a Detailed Qualitative analysis of the above report by requesting the free sample pages from Request for your Free Sample PDF/Online Access.
The market for next-generation diabetes therapy and drug delivery is highly competitive, with major competitors such as Abbott Laboratories, Novo Nordisk, Dexcom, and Medtronic vying for market share. These businesses are committed to innovation, creating cutting-edge products like continuous glucose monitors and intelligent insulin delivery systems. In this quickly changing industry, companies often look to grow their portfolios and solidify their market positions through strategic alliances, mergers, and acquisitions.
May 2021: The medical technology company Medtronic plc has been awarded the CE (Conformité Européenne) Mark for its Guardian 4 sensor3. This sensor eliminates the need for fingersticks while calibrating or making treatment decisions for diabetes. Due to the CE Mark, this next-generation sensor can be linked with Medtronic or the MiniMed 780G insulin pump system. (Source:https://news.medtronic.com/2021-05-26-Medtronic-Secures-Two-CE-Mark-Approvals-for-Guardian-4-Sensor-for-InPen-MDI-Smart-Insulin-Pen) September 2020: DexCom, Inc., the leading provider of real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced the creation of the first registry in history dedicated to monitoring the results of CGM use in hospitals during the COVID-19 pandemic by patients and healthcare professionals. (Source:https://investors.dexcom.com/news/news-details/2020/Dexcom-Announces-First-Ever-Registry-Dedicated-to-Tracking-Outcomes-of-In-Hospital-Real-Time-CGM-Use-in-Response-to-the-COVID-19-Pandemic/default.aspx) April 2020: Dexcom announced that the company is temporarily making its Dexcom G6 CGM System available for remote patient monitoring in the hospital setting due to the COVID-19 public health crisis, the need to maintain personal protective equipment, and the desire to decrease the frequency of hospital staff exposure to the coronavirus. (Source:https://www.dexcom.com/news/dexcom-cgm-hospital-covid19)Top Companies Market Share in Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The published report edition delivers Middle East and Africa Market size analysis from 2019 till the forecast period of 2031. We have included analysis of top performing countries such as (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA) and their Market segmentation by Product, Demographic, Indication, End User, etc. This will help you to understand detailed segment profile, revenue generation, growth patterns, trends, and differences among the each segments.
Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery market Product size and share analysis, have been revealed under this section. This section offers market size, revenue share, y-o-y growth rate along with market attractiveness for each type. This will help you to understand which type held largest revenue share along with its compound annual growth rate (CAGR) of Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market.
With the help of type segment analysis, companies can understand which type has potential to invest along with its driving factors, current trends and other key factors. The timeline covered in the published North America Report edition is 2019 to 2031.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
Demographic segment analysis is key parameter for key companies and new entrants offering versatile products or services, helping them customize products to meet the need of different user scenarios. Based on the application segment analysis, key companies can choose which application segments to target in the Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market. Our experts continuously monitor market dynamics and consumer trends of the each application to evaluate the attractiveness and potential of each segment. In terms of revenue, we can also provide the cross split of types in the each application for year 2019-2031. To understand more please connect with our sales team.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
The Current Published report Editon on the website includes the following list of countries analysis whereas in case you looking to access any other country or states level data under Middle East and Africa then please revert us to access the exclusive Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery industry report Edition.
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Bio :Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical...Read More
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market is witnessing significant growth in the near future.
In 2023, the Inhalable Insulin segment accounted for noticeable share of Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market and is projected to experience significant growth in the near future.
The Adult Population segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies , and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Product | Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas |
Demographic | Adult Population, Child Population |
Indication | Type 1 Diabetes, Type 2 Diabetes |
End User | Diagnostic/Clinics, ICUs, Home Healthcare |
List of Competitors | Not Disclosed! Request To Preview the List |
Chapter 1 Middle East and Africa Market Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 2 Competitor Analysis (Subject to Data Availability (Private Players))
Chapter 3 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 4 Market Split by Product Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 5 Market Split by Demographic Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 6 Market Split by Indication Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 7 Market Split by End User Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery market
Chapter 8 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Inhalable Insulin have a significant impact on Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery market? |
What are the key factors affecting the Inhalable Insulin and Oral Insulin of Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market? |
What is the CAGR/Growth Rate of Adult Population during the forecast period? |
By type, which segment accounted for largest share of the Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market? |
Which region is expected to dominate the Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market
Request Sample